tiprankstipranks
Carisma Therapeutics (CARM)
NASDAQ:CARM
Holding CARM?
Track your performance easily

Carisma Therapeutics (CARM) Income Statement

1,539 Followers

Carisma Therapeutics Income Statement

Last quarter (Q3 2024), Carisma Therapeutics's total revenue was $80.20M, an increase of 1995.74% from the same quarter last year. In Q3, Carisma Therapeutics's net income was $-12.70M. See Carisma Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 258.87M$ 14.92M$ 9.83M$ 26.50M$ 11.24M-
Cost of Revenue
------
Gross Profit
$ 338.12M$ 94.18M$ 9.80M$ 26.50M$ 11.24M-
Operating Expense
$ 87.04M$ 103.65M$ 66.00M$ 35.09M$ 32.31M$ 108.49M
Operating Income
$ -66.77M$ -88.73M$ -56.16M$ -8.55M$ -21.08M$ -108.49M
Net Non Operating Interest Income Expense
$ 2.78M$ 1.94M$ 3.15M$ 17.00K--
Other Income Expense
$ -30.90M$ -84.00K$ -1.92M$ -25.06M$ -11.30M$ -991.00K
Pretax Income
$ -64.41M$ -86.88M$ -61.23M$ -8.65M$ -20.95M$ 35.74M
Tax Provision
$ -197.00K-$ -3.88M$ -8.27M$ 1.45M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -63.80M$ -86.88M$ -61.23M$ -40.78M$ -28.35M$ 35.74M
Basic EPS
$ -0.68$ -2.59$ -2.00-$ -3.80$ -23.60
Diluted EPS
$ -0.68$ -2.59$ -2.00-$ -3.80$ -23.60
Basic Average Shares
$ 41.71B$ 33.52M$ 10.03M$ 9.12M$ 5.91M$ 4.55M
Diluted Average Shares
$ 41.71B$ 33.52M$ 10.03M$ 9.12M$ 5.91M$ 4.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 87.04M$ 103.65M$ 66.00M$ 35.09M$ 32.31M$ 108.49M
Net Income From Continuing And Discontinued Operation
$ -63.80M$ -86.88M$ -61.23M$ -40.78M$ -28.35M$ -107.50M
Normalized Income
$ -63.78M$ -68.55M-$ -36.54M--
Interest Expense
------
EBIT
$ -65.06M$ -88.73M$ -58.08M$ -40.79M$ -28.38M$ 35.74M
EBITDA
$ -56.08M$ -85.89M$ -56.19M$ -40.11M$ -27.93M$ 35.94M
Currency in USD

Carisma Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis